Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis.
Matsuo
T
T
Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Sumoto, Japan.
Chikahira
Y
Y
Yamada
T
T
Nakao
K
K
Ueshima
S
S
Matsuo
O
O
D001120:Arginine / Q000031:analogs & derivatives; D001792:Blood Platelets / Q000276:immunology / Q000378:metabolism; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D010875:Pipecolic Acids / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D006435:Renal Dialysis / Q000009:adverse effects; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*; D013921:Thrombocytopenia / Q000097:blood* / Q000139:chemically induced
D007074:Immunoglobulin G; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; D013917:Thrombin; C031942:argatroban